Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGCLA.L Regulatory News (GCLA)

  • There is currently no data for GCLA

Stabilisation Notice

19 Oct 2007 11:15

Credit Suisse Securities (Eur) Ltd19 October 2007 PRE-STABILISATION ANNOUNCEMENT Not for distribution, directly or indirectly, in or into the United States orany jurisdiction in which such distribution would be unlawful. Grupo Clarin 19th October 2007 Pre-Stabilisation Notice Pursuant to Core Dealing Rule 3060-3061, Credit Suisse Securities (Europe)Limited hereby notifies the London Stock Exchange that it and its affiliates maystabilise the offering of the Security below Credit Suisse Securities (Europe) Limited, hereby gives notice that theStabilising Manager(s) named below may stabilise the offer of the followingsecurities in accordance with Commission Regulation (EC) No. 2273/2003implementing the Market Abuse Directive (2003/6/EC). The securities: Issuer: Grupo Clarin ISIN US40052A2096 REGs US40052A1007 144aGuarantor (if any): Aggregate nominal amount 19,250,000(Offering): Description: GDR Ratio 1 GDR : 2 B Share Offer price: USD 18.50 Other offer terms: Stabilisation: Stabilising Manager(s): Credit Suisse Securities (Europe) Limited Contact Felipe Portillo 44 20 7888 6522 Stabilisation period expected 19th October 2007 at approximately 12.00pm London time;to start on: Stabilisation period expected 16th November 2007 (30 days after the proposed issue date of theto end no later than: securities) Over-allotment option 15 % of the Offering Existence, maximum size and The Stabilising Manager(s) may over-allot the securities conditions of use of to the extent permitted in accordance with applicable law. over-allotment facility: In connection with the offer of the above securities, the Stabilising Manager(s)may over-allot the securities or effect transactions with a view to supportingthe market price of the securities at a level higher than that which mightotherwise prevail. However, there is no assurance that the Stabilising Manager(s) will take any stabilisation action and any stabilisation action, if begun,may be ended at any time. Any stabilisation action or over-allotment shall beconducted in accordance with all applicable laws and rules. This announcement is for information purposes only and does not constitute aninvitation or offer to underwrite, subscribe for or otherwise acquire or disposeof any securities of the Issuer in any jurisdiction. This material was produced by Credit Suisse Securities (Europe) Limited, a firmregulated and authorised by The Financial Services Authority (the "FSA"). Thisannouncement and the offer of the securities to which it relates are onlyaddressed to and directed at persons outside the United Kingdom and persons inthe United Kingdom who have professional experience in matters related toinvestments or who are high net worth persons within article 12(5) of theFinancial Services and Markets Act 2000 (Financial Promotion) Order 2005 andmust not be acted on or relied on by other persons in the United Kingdom. In addition, if and to the extent that this announcement is communicated in, orthe offer of the securities to which it relates is made in, any EEA Member Statethat has implemented Directive 2003/71/EC (together with any applicableimplementing measures in any Member State, the "Prospectus Directive") beforethe publication of a prospectus in relation to the securities which has beenapproved by the competent authority in that Member State in accordance with theProspectus Directive (or which has been approved by a competent authority inanother Member State and notified to the competent authority in that MemberState in accordance with the Prospectus Directive), this announcement and theoffer are only addressed to and directed at persons in that Member State who arequalified investors within the meaning of the Prospectus Directive (or who areother persons to whom the offer may lawfully be addressed) and must not be actedon or relied on by other persons in that Member State. This announcement is not an offer of securities for sale into the United States.The securities have not been, and will not be, registered under the UnitedStates Securities Act of 1933 and may not be offered or sold in the UnitedStates absent registration or an exemption from registration. There will be nopublic offer of securities in the United States. This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
12th May 20151:00 pmRNSResults for the First Quarter 2015 (1Q15)
7th May 20156:12 pmRNSPayment of Cash Dividends
7th May 20157:54 amRNSNotice of Q1 2015 Results
30th Apr 20157:30 amRNSGCSA Holds Annual Ordinary Shareholders' Meeting
27th Apr 20157:17 amRNSGCLA responds to shareholder information request
24th Apr 20157:39 amRNSBoard Proposes External Auditors for 2015
16th Apr 20157:33 amRNSProposed Change in Allocation of Retained Earnings
30th Mar 20157:00 amRNSMinutes of the Meeting of the Board of Directors
18th Mar 20154:55 pmRNSGrupo Clarin to respond to appeal
18th Mar 20157:00 amRNSAnnual Financial Report
12th Mar 20153:45 pmRNSSecond Price Monitoring Extn
12th Mar 20153:40 pmRNSPrice Monitoring Extension
11th Mar 20155:58 pmRNSBoard Members' Fee Proposal
11th Mar 201512:00 pmRNSResults for Fourth Quarter and Full Year of 2014
5th Mar 20157:00 amRNSBoard Member Leave of Absence
2nd Mar 20157:00 amRNSNotice of Results
23rd Feb 20157:00 amRNSCourt grants injunction
15th Dec 20147:00 amRNSLeave of Absence Request
10th Dec 20147:00 amRNSCourt Grants Injunction
21st Nov 201412:49 pmRNSDividend Declaration
12th Nov 20143:45 pmRNSSecond Price Monitoring Extn
12th Nov 20143:40 pmRNSPrice Monitoring Extension
11th Nov 201412:03 pmRNSResults for Nine Months and Third Quarter of 2014
3rd Nov 20145:12 pmRNSCall and Presentation on 3rd Quarter Results
3rd Nov 20145:07 pmRNSCourt Grants Interim Injunction
10th Oct 20147:43 amRNSAFSCA Rejects Plan
10th Oct 20147:00 amRNSVice Chairman requests leave of absence
7th Oct 20147:21 amRNSBoard of Directors Receives Note from Shareholder
30th Sep 20143:45 pmRNSSecond Price Monitoring Extn
30th Sep 20143:40 pmRNSPrice Monitoring Extension
29th Sep 20144:13 pmRNSLeave of Absence request
25th Sep 20147:15 amRNSGCLA Holds Extraordinary Shareholders' Meeting
18th Sep 20147:00 amRNSGrupo Clarin shareholder summoned to Court
17th Sep 20147:40 amRNSGCLA Responds to Shareholder Information Request
21st Aug 20147:58 amRNSSteps Towards Media Law Compliance
18th Aug 20147:53 amRNSBoard of Directors Considers AFSCA Resolution
15th Aug 20147:00 amRNSAFSCA Rejects Request to Amend Proposal
11th Aug 20141:00 pmRNSResults for First Half and Second Quarter 2014
4th Aug 20143:46 pmRNSSecond Price Monitoring Extn
4th Aug 20143:40 pmRNSPrice Monitoring Extension
1st Aug 20145:30 pmRNSConference call to discuss Q2 2014 Results
15th Jul 20147:03 amRNSGCLA reconvenes Extraordinary Shareholders Meeting
14th Jul 20143:35 pmRNSOffers Relating to Unit 6 and other matters
2nd Jul 20147:14 amRNSGCLA holds Extraordinary Shareholders' Meeting
1st Jul 20147:22 amRNSGrupo Clarin Shareholders' Meeting Adjourned
30th Jun 20147:28 amRNSGCLA Considers Offers Related to Units 4, 5 and 6
25th Jun 20147:17 amRNSResponse to Shareholder Note
23rd Jun 20147:46 amRNSResponse to Shareholder Information Request
19th Jun 20147:39 amRNSPublication of Prospectus
9th Jun 20145:31 pmRNSBoard of Directors Receives Note from Shareholder

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.